This ranking evaluates how Fortune 500 companies are deploying AI, and how technology leaders value those investments relative to industry peers.

Fortune AIQ 75

The companies on the Global 500 employ 70.2 million people, and their revenue represents more than one-third of the world’s GDP.

Fortune Global 500

With a combined revenue of $21 trillion and $2.1 trillion in profits, the 2026 Fortune 500 is the definitive list of America's largest companies.

Fortune 500

AI is a major force shaping this year’s list—but it’s far from the only story.

World's Most Admired Companies

The corporations on our annual list of the world's 500 largest companies combined to generate $41.7 trillion in revenue over the past year.

Almost $20 trillion in revenue—and a record-breaking $1.87 trillion in profits. Introducing the 2025 Fortune 500, the definitive list of the biggest companies in America.

The corporations on our annual list posted aggregate revenues of $41 trillion for the second year in a row.

Industries included in the sector are beverages, food consumer products, and food production.

Fortune Sector Leaders: Food, Beverages, and Tobacco

The Fortune 500, in its 70th year in 2024, ranks the biggest U.S. companies by revenue.

The 26th edition of the list shows how much esteem Big Tech giants command among other business leaders.

The 25th Fortune World’s Most Admired Companies list suggests that tech giants’ peers respect them as much as ever.

The corporations on our annual list of the world’s largest companies delivered a record $41 trillion in aggregate revenues.

GLOBAL-500-2023-Archer-Daniels-Midland

The Fortune 500, in its 69th year in 2023, ranks the biggest U.S. companies by revenue.

F500 2023 035 Archer Daniels Midland_ADM_LATAM_PortSantos_2

Archer Daniels Midland (ADM) produces industrial ingredients as varied as high-fructose corn syrup and the cotton cellulose pulp used to make paper. It also runs a commodities trading operation for goods like grain and corn. 
<ul> 
 	<li>ADM’s ag services division, which sells seeds for industrial agriculture, had a strong year. Its revenue surged 18.7%, and operating income soared 58% as constrained supplies kept prices of commodities like corn, wheat, and soybeans high.</li> 
 	<li>Meanwhile, ADM’s nutrition business, which produces goods from livestock feed to food coloring, proved a drag on company performance: Sales grew just 6.5%, a sluggish pace the company attributed to global currency fluctuations and lower consumption amid rising inflation.</li> 
 	<li>In August 2022 ADM entered a joint venture with South Korean chemical company LG Chem to produce sustainable bioplastics in the U.S.</li> 
</ul>

Just as it dominates our economy, Big Tech now dominates Fortune’s annual ranking of corporate reputation.

Aggregate sales hit $37.8 trillion last year—an increase of 19%, the highest annual growth rate in the list’s history.

This year’s Fortune 500 marks the 68th running of the list.

F500 2022-Archer Daniels Midland

ADM is a nutrition, food processing, and commodities company whose broad product lineup ranges from high fructose corn syrup to products used in gasoline and cosmetics. The company climbed 12 spots to No. 38 on this year’s Fortune 500; its revenue shot up 32.5% in 2021 to $85 billion, driven by big sales gains for projects as varied as ethanol and vegetable oil. ADM expanded its footprint in pet nutrition, acquiring majority stakes in four pet food companies for $450 million. It also acquired South African flavor distributor Comhan in February 2022 for an undisclosed amount, aiming to boost its production of cocoa, cocoa butter, and chocolate.

After a year in which humanity leaned more heavily than ever on tech giants, see which companies topped Fortune's ranking of corporate reputation.

Total revenue for the world’s biggest companies fell 4.8% to $31.7 trillion this year—the first decline in half a decade.

G500 147 Archer Daniels Midland

<span data-sheets-value="{&quot;1&quot;:2,&quot;2&quot;:&quot;The Chicago-based agricultural processor’s business spans 200 countries and touches everything from animal feed and human food to cosmetics, alcohol, and paint. Its annual performance has much to do with market conditions and commodity prices: In 2020, sales dipped 0.5% due to lower sales volumes of rice, ethanol, oils, and corn by-products. (ADM idled some facilities because of decreased demand last year.) Still, profits increased 28.5% over the previous year owing to more robust global trade—particularly between the U.S. and China—and strong demand for specialty ingredients like probiotics and plant-based proteins.&quot;}" data-sheets-userformat="{&quot;2&quot;:12673,&quot;3&quot;:{&quot;1&quot;:0},&quot;10&quot;:2,&quot;11&quot;:4,&quot;15&quot;:&quot;Calibri&quot;,&quot;16&quot;:11}">The Chicago-based agricultural processor’s business spans 200 countries and touches everything from animal feed and human food to cosmetics, alcohol, and paint. Its annual performance has much to do with market conditions and commodity prices: In 2020, sales dipped 0.5% due to lower sales volumes of rice, ethanol, oils, and corn by-products. (ADM idled some facilities because of decreased demand last year.) Still, profits increased 28.5% over the previous year owing to more robust global trade—particularly between the U.S. and China—and strong demand for specialty ingredients like probiotics and plant-based proteins.

These companies use the creative tools of capitalism—including the profit motive—to address society’s unmet needs.

CTW-2021-27-ADM

ADM has been on a quest to turn plants into meat substitutes since the 1950s, and claims the title of inventor of the soy veggie patty. Today, as a $64 billion ingredient company supplying global food brands, it may be the biggest plant-based protein producer you’ve never heard of. Its 10 joint ventures and investments in the category range from growing meat from animal cells to creating protein through fermentation to building the world’s largest insect protein production facility (it’s designed to convert flies into animal feed). These deals are key to ADM’s effort to remake itself into more than an agri-giant processor of commodity crops. ADM expects the $10 billion plant-protein sector to triple in size over the next decade as consumers become more concerned about the impact of their diets on the environment.

Change the World

This year’s Fortune 500 marks the 67th running of the list.

F500-2021-51-Archer Daniels Midland

For an astounding 13th straight year, Apple claims the top spot in Fortune’s annual ranking of corporate reputation, based on a survey of almost 3,800 executives, directors, and analysts.

This year's Fortune Global 500 generated $33.3 trillion in revenues and $2.1 trillion in profits.

G500-2020-168-Archer-Daniels-Midland

The agricultural commodities and food processing giant, which fell 13 places on this year’s list, faced a bevy of challenges in 2019, including spring flooding in the American Midwest, an African swine fever outbreak in China, and continuing trade tensions between the U.S. and China. Revenues rose only 0.5% from the previous year, due to the weak performance of ADM’s ag services and oilseeds division, as well as its carbohydrate solutions unit. Both were challenged by lower sales volumes and commodity price declines. A bright spot was the company’s nutrition business, where sales were up 50%, largely due to acquisitions including that of Neovia, a French animal nutrition company.

This year's Fortune 500 marks the 66th running of the list.

F500-2020-054-Archer-Daniels-Midland

The agricultural commodities and food processing giant, which falls five places on this year’s list, faced a bevy of challenges in 2019, including spring flooding in the American Midwest, an African swine fever outbreak in China, and continuing trade tensions between the U.S. and China. Revenues rose only 0.5% from the previous year due to the weak performance of ADM’s ag services and oilseeds division, as well as its carbohydrate solutions unit. Both were challenged by lower sales volumes and commodity price declines. A bright spot was the company’s nutrition business, where sales were up 50% largely due to acquisitions like Neovia, a French animal nutrition company.

Here are the World's Most Admired Companies for 2019 as ranked in their industries. See who made the list.

This year's Fortune Global 500 generated $27.7 trillion in revenues and $1.5 trillion in profits.

This year's Fortune 500 marks the 65th running of the list.

Here are the World's Most Admired Companies for 2018 as ranked in their industries. See who made the list.

This year's Fortune 500 marks the 64th running of the list.

Here are the World's Most Admired Companies for 2017 as ranked in their industries. See who made the list.

This year's Fortune 500 marks the 63rd running of the list.

Here are the World's Most Admired Companies for 2016 as ranked in their industries. See who made the list.

This year's Fortune Global 500 generated $27.6 trillion in revenues and $1.5 trillion in profits.

This year's Fortune 500 marks the 62nd running of the list.

Business insiders have spoken: Asked which companies they most admire, more than 4,100 executives, directors, and analysts chose these top 50 All-Stars.

The world's 500 largest companies generated $31.2 trillion in revenues and $1.7 trillion in profits in 2014. Together, this year's Fortune Global 500 employ 65 million people worldwide and are represented by 36 countries.

This year's Fortune 500 marks the 61st running of the list. Wal-Mart claims the top spot again. See who made the list.

Global business is back. After limping through a worldwide financial crisis and economic slowdown, the 500 largest companies ranked by revenues shattered all sorts of performance records in 2013: They racked up combined revenues of $31.1 trillion, up 2.5% from 2012, and profits soared 27% to nearly $2 trillion. China’s 95 companies (up from 89 last year) posted $5.8 trillion in revenues. The U.S. has four fewer companies on the list than last year but remains (for now) the country leader, with 128 corporations on the list—including No. 1 Wal-Mart Stores—reporting $8.6 trillion in revenues. 

Wal-Mart stayed on top as its sales crept closer to half-a-trillion dollars. Apple moved into the top five. And UnitedHealth Group continued its steady climb. 

Change The World

Impact Segment

Sector

Industry

Current All-Star Rank

Previous All-Star Rank

Industry Rank

Previous Industry Rank

Overall Score

Innovation

People Management

Use of Corporate Assets

Social Responsibility

Quality of Management

Financial Soundness

Long-Term Investment Value

Quality of Products/Services

Global Competitiveness

Key Financials (last Fiscal Year)

Revenues ($M)

Profits ($M)

Assets ($M)

Total Stockholder Equity ($M)

Profit Ratios

Profit as % of Revenues

Profits as % of Assets

Profits as % of Stockholder Equity

Earnings Per Share (last Fiscal Year)

Earnings Per Share ($)

EPS % Change (from prior fiscal year)

EPS % Change (5 year annual rate)

EPS % Change (10 year annual rate)

Total Return

Total Return to Investors (last year)

Total Return to Investors (5 year, annualized)

Total Return to Investors (10 year, annualized)

Archer Daniels Midland (ADM), founded in 1902, is one of the largest global players in food processing and commodities trading. Headquartered in Chicago, ADM operates more than 800 facilities worldwide, processing oilseeds, corn, wheat, and other agricultural products. The company is a leading supplier of food ingredients, animal feed, and biofuels. ADM plays a crucial role in the global food supply chain, connecting crops to markets and providing essential ingredients to various industries.

Q2 2026

Q1 2026

Q4 2025

Q3 2025

Q2 2025

Q1 2025

Q4 2024

Archer Daniels Midland (ADM): Company Profile, Stock Price, News, Rankings

legacy

Archer Daniels Midland

archer daniels midland

Good morning, and welcome to the ADM Second Quarter twenty twenty five Earnings Conference Call. All lines have been placed on a listen only mode to prevent background noise. As a reminder, this conference call is being recorded. I'd now like to introduce your host for today's call, Megan Britt, Vice President, Investor Relations for ADM. Ms. Britt, you may begin.

Welcome to the second quarter earnings conference call for ADM. Our prepared remarks today will be led by Juan Luciano, Chair of the Board and Chief Executive Officer and Manish Padalawala, our EVP and Chief Financial Officer. We have prepared presentation slides to supplement our remarks on the call today, which are posted on the Investor Relations section of the ADM website and through the link to our webcast. Some of our comments and materials may constitute forward looking statements that reflect management's current views and estimates of future economic circumstances, industry conditions, company performance and financial results. These statements and materials are based on many assumptions and factors that are subject to numerous risks and uncertainties.

ADM has provided additional information in its reports on file with the SEC concerning assumptions and factors that could cause actual results to differ materially from those in this presentation and the materials. Unless otherwise required by law, AAM assumes no obligation to update any forward looking statements due to new information or future events. In addition, during today's call, we'll refer to certain non GAAP or adjusted financial measures. Reconciliations of these non GAAP financial measures to the most directly comparable GAAP financial measures are available in our earnings press release and presentation slides, which can be found in the Investor Relations section of the ADM website. I'll now turn the call over to Juan.

Thank you, Megan. Hello, and welcome to all who have joined the call. Please turn to Slide four. Today, ADM reported adjusted earnings per share of $0.93 Total segment operating profit was $830,000,000 for the quarter. Our trailing fourth quarter adjusted ROIC was 6.9% and cash flow from operations before working capital changes was $1,200,000,000 for the first half of the year.

The team focus has been on managing what we can control in a dynamic environment and we continue to drive positive momentum in those areas in the second quarter. Our carbohydrate solutions team again delivered steady results with a strong execution and disciplined risk management. Team The Nutrition team drove another quarter of sequential improvement, led by our Flavors and Animal Nutrition portfolios. We also made important progress in getting our Decatur East plant back online, already ramping to our planned run rates. As Services and Oilseeds performed in line with our expectations, the team worked to offset lower margins this quarter through targeted organizational realignment and network consolidations, enabling us to be well positioned to take advantage of expected improved conditions in the second half of the year.

Across our global operations network, our efforts to improve operational resiliency delivered outstanding results. We achieved our best performance in limiting unscheduled and unplanned downtime in more than five years. We're also proud to have been named as one of America's greatest workplaces in manufacturing, a testament to the tireless efforts of our colleagues across the ADM operations workforce. The external environment became clear in some critical areas for our business throughout the quarter. The U.

S. Administration drove positive tax and biofuel policies that are helping biofuel producers make better decisions about production rates and feedstock demand, while also supporting an uplift in crush and biodiesel margins. The agility in which we manage the 2025 demonstrates our team's ability to drive our strategy forward and manage the dynamics of the external environment, while focusing attention on the self help and execution excellence agenda we outlined earlier in the year. Let's take a closer look at our progress on key strategic objectives in the quarter. Please turn to Slide five.

We're making a strong progress against the areas of self help we identified at the beginning of the year. The balance of efforts across cost management, execution excellence, targeted simplification, strategic growth and capital discipline are providing an important foundation to work from. Let me share a few examples of what we accomplished in the quarter. We're continuing our portfolio management activities. We made decisions to cease operations at certain facilities that no longer align with our long term goals, including several AS and O origination sites globally, a port transload facility in Florida, an aquaculture plant in Ecuador, a pet and animal nutrition plant in Brazil and two assets no longer strategic to the Specialty Ingredients business.

We focused on optimizing our AS and O network and aligning our asset base to the most critical parts of the business, while ensuring we effectively manage uptime and production capacity. And we announced our intention to move our Lubbock, Texas cottonseed plant into a joint venture. As I mentioned earlier, we achieved a critical milestone in recommissioning our Decatur East facility and are currently ramping up to planned production levels. This will have a positive impact on cost within our Specialty Ingredients business as we move through the back half of the year. Through a combination of these efforts and others throughout the first half of the year, we remain on track for our targeted 500,000,000 to $750,000,000 in aggregate cost savings over the next three to five years.

We're also continuing our capital discipline focus with an eye on returning capital to shareholders. And following our Q1 earnings call, we announced our three hundred and seventy fourth consecutive quarterly dividend. And while we've been keeping our efforts in cost and capital management at the forefront, we have never stopped smart organic investments that provide us options to accelerate growth at the appropriate time. ADM's integrated business model provides significant advantages to generate value across our entire production ecosystem. A few examples include: repositioning co products from our operations into new solutions such as converting fatty acid residues found in waste materials into biofuels addressing a growing carbon economy through the expansion of our decarbonization capabilities in carb solutions and taking advantage of available capacity in nutrition plants to expand product lines and enter new markets.

All of these represent ways ADM can reduce waste, accretively deploy capital and increase returns. As we look to the back half of 2025 from an external perspective, we anticipate increasing biofuels and trade policy clarity that accelerate our ability to create positive economic opportunities and drive additional investments such as these throughout our business and the agriculture sector. As public policy increasingly supports the agricultural sector, ADM is poised to play a pivotal role in driving that progress. In The U. S, for instance, as policies are finalized to accelerate the adoption of renewable fuels, ADM is ready to lead, advancing innovative solutions that open new, high value markets for American farmers and strengthen the broader bioeconomy.

We will also continue to shape our own path through the self help agenda that is already driving impacts that help offset some of the market dynamics seen in the first half of the year. Because several external factors and self help efforts will activate in the third and fourth quarters, we are tightening our expectation for adjusted earnings per share and expect it to land around $4 per share for full year 2025. We believe ADM is in a solid position to exit 2025 with operational momentum and we are confident that our team's ability to execute against our strategy will set the company up for a strong finish to the year and launch into 2026. With that, let me hand it over to Manish to share a deeper dive into second quarter financial results and our 2025 outlook. Manish?

Thank you, Juan. Please turn to slide six. AS and O segment operating profit for the second quarter was $379,000,000 down 17% compared to the prior year quarter as limited clarity on legislative and biofuel policy continued to impact margins in the segment. In the Ag Services sub segment, operating profit was $113,000,000 down 7% versus the prior quarter driven primarily by lower global trade and South American origination results. Global trade results were lower relative to the same quarter last year largely due to the lower trading volumes partially related to the trade policy uncertainty as well as lower margins due to lower commodity prices, negative freight timing and currency impacts.

South American origination results were lower primarily due to lower volume and margins stemming from the loss of operations at a key port facility in Brazil and foreign exchange impacts. North American origination results improved in the quarter due to higher margins and volumes as well as from a timing benefit associated with receiving $19,000,000 in proceeds from a USDA grant earlier this year compared to in 2024. There were net negative timing impacts of approximately $27,000,000 year over year. In the crushing sub segment, operating profit was $33,000,000 down 75% from the prior year quarter. Consistent with our expectations for the quarter, both global soybean and canola crush execution margins were lower than the prior year quarter.

Global executed crush margins were approximately $7 per ton lower in soybeans compared to the prior year quarter and approximately $29 per ton lower in canola. By region, crush margins were down significantly in North America. North America soybean crush margins were negatively impacted by higher crush rates and lower soybean oil demand stemming from biofuel policy uncertainty earlier in the quarter. North America canola crush margins were approximately $50 per ton lower due to headwinds from trade policy and lower canola oil demand for biofuel production. There were net positive timing impacts of approximately $37,000,000 year over year.

In the Refined Products and Other sub segment, operating profit was $156,000,000 up 14% compared to the prior year quarter as positive timing impacts offset lower biodiesel and refining margins. In EMEA, margins declined due to significantly lower biodiesel export volumes. In North America, positive timing impacts offset lower biodiesel and refining margins which were negatively impacted by additional industry crush capacity and lower demand for vegetable oils due to biofuel policy uncertainty. There were net positive timing impacts of approximately $119,000,000 year over year. Equity earnings from the company's investment in Wilmar was $77,000,000 up 13% compared to the prior year quarter.

Turning now to slide seven. For the second quarter, Carbohydrate Solutions segment operating profit was $337,000,000 down 6% compared to the prior year quarter. In Starches and Sweeteners sub segment operating profit was $3.00 $4,000,000 down 6% compared to the prior year quarter. In EMEA, sweeteners and starches volumes and margins declined as higher corn costs due to crop quality issues continued to negatively impact results. In North America, sweeteners and starches results were up slightly as higher liquid sweetener and con co product margins offset the negative impact of weaker starch margins and volumes and lower wet mill ethanol margins.

Global wheat milling margins and volumes also improved relative to the prior year quarter largely due to volume growth with key customers. In the Vantage Corn Processor sub segment, operating profit was $33,000,000 flat relative to the prior year quarter as higher ethanol volumes and improved risk management largely offset lower ethanol margins. Overall, ethanol EBITDA margins per gallon were positive in the quarter though lower than the prior year quarter. Turning to slide eight. In the second quarter, Nutrition segment revenues were $2,000,000,000 the up approximately 5% compared to the prior year quarter.

The increase includes a $55,000,000 benefit from a contract cancellation in Health and Wellness, the full amount of which is not included in the Nutrition segment operating profit. Excluding this benefit, Human Nutrition revenue was up approximately 4%, primarily driven by flavors growth, partially offset by headwinds related to supply challenges from Decatur East. Animal Nutrition revenue was down 2% as negative currency impacts and lower volumes offset mix benefits. Nutrition segment operating profit was $114,000,000 for the second quarter, up 5% versus the prior year quarter. Human Nutrition sub segment operating profit was $92,000,000 down 11% compared to the prior year quarter as improved performance in Flavors was more than offset by declines in Specialty Ingredients and Health and Wellness.

In Specialty Ingredients, operating profit declined due to lower margins and impacts related to the Decatur East plant. In Health and Wellness, higher margins from Biotics and improved product mix were more than offset by reduced tolling margins from a contract cancellation. Animal Nutrition sub segment operating profit of $22,000,000 was higher than the prior year quarter due to higher margin supported by ongoing turnaround action. Please turn to slide nine. For the first half of the year, the company generated cash flow from operations before working capital of approximately $1,200,000,000 down relative to the prior year period due to lower segment operating profit.

We continue to make progress with our actions to ensure working capital excellence through stronger rigor on working capital planning, inventory rationalization, improvement of key account payable metrics and more timely collection of past due balances. For example, inventories decreased by $2,200,000,000 during the first half of this year as compared to a $1,400,000,000 decrease in the prior year period in part due to improved management of volumes. Solid cash generation and our strong balance sheet remain important differentiators for the company. Our leverage ratio was 2.1 times for the quarter end and we will continue to seek opportunities to further strengthen our balance sheet to enhance financial flexibility. We are dedicated to organically investing in the business to elevate returns and create long term value.

To this end, we have been very prudent with our CapEx spending. Year to date, we have invested $596,000,000 in capital expenditures and have lowered our expected CapEx spend range to $1,300,000,000 to $1,500,000,000 from 2025 down from previous expectations of $1,500,000,000 to $1,700,000,000 At the same time, we remain steadfast in our commitment to returning cash to shareholders and we returned $495,000,000 to shareholders in the form of dividends during the 2025. Turning to slide 10, we have provided details to support our 2025 outlook. With greater visibility regarding the third quarter and additional clarity on emerging policy tailwind, we have tightened our range and now expect adjusted earnings per share to be approximately $4 per share for the full year 2025. Tax and biofuel policy proposals introduced towards the end of the second quarter and beyond have now created market insight to incentivize higher biofuel and renewable diesel production levels.

In June, the Environmental Protection Agency released its first Renewable Volume Obligation or RVO proposal for 2026 and 2027 with favorable provisions for domestic feedstocks. In July, the tax reconciliation package signed by the administration improved and extended the 45Z biofuel producer tax credit for an additional two years to 2029 and clarify that the credit is limited to fuels created from North American feedstocks. With the favorable proposed RVO and finalization of the 45Z producer tax credit, soybean oil has rallied and board crush margins have improved. Combined with the focused actions of our teams on network consolidation and cost savings, we expect to be in a better position to capture opportunities as we enter the fourth quarter and move through the final months of the year. Let me provide some color on several assumptions for the second half.

We are closely monitoring customer demand and have embedded expectations for lower volumes in certain pockets and geographies in our guidance. With policy developments coming at the end of the second quarter, we had already booked a portion of our third quarter business which will limit our ability to take full advantage of higher expected margins from these developments in the third quarter. We expect soybean crush margins in the third quarter to be in a similar range to the second quarter. We expect improved AS and O margins will primarily benefit our fourth quarter results where we project global soybean crush margins to be in the range of $60 to $70 per metric ton and global canola crush margins to be in the range of $55 to $65 per metric ton. We also expect improvement in Ag Services in the fourth quarter as we expect strong crops in North America and a solid North American export season supported by increased trade policy clarity.

We expect Carb Solutions to continue to be impacted by softness in starch demand for paper and corrugated box and higher corn costs in EMEA related to corn quality issues. Robust industry wide ethanol production is expected to sustain pressure on margins and we anticipate for the year 2025 a mid single digit decline in overall ethanol EBITDA margins compared to the prior full year. We anticipate continued improvement in Nutrition through a focus on supply chain excellence and our Decatur East plant returning to planned full production. Finally, just a reminder, during the 2024, we had $231,000,000 in insurance proceeds with $96,000,000 in the third quarter and the balance in the fourth quarter. The third quarter insurance proceeds were largest in Crop Solutions and will impact third quarter year over year comparisons in that segment.

To close, we are making progress. My top priority coming to ADM was to remediate the material weakness. And this quarter we announced that we have successfully remediated the material weakness in internal controls for segment disclosures related to reporting, pricing and measurement. Going forward, we will continue to focus on broader initiatives that will enhance our transparency and compliance processes while maintaining an effective operating environment. We have also aggressively acted on opportunities to improve operational performance and lower costs and we are seeing through these actions that our assets are running better and we are benefiting from the restored and ramping operations at our Decatur East plant.

We also continue to work in a measured manner to simplify our portfolio to enhance focus on core competencies while unlocking additional capital to drive value and position the company for long term success. In particular on cash, we have delivered an improvement in working capital efficiency and we have taken actions to further optimize our CapEx. These efforts position us in our ability to navigate the current dynamic environment and reinforce our confidence in delivering on our commitments. Before I hand it back to Juan, I want to take a moment to thank all my ADM colleagues for their dedication and focus in delivering for our customers and helping to create long term value for our shareholders. Back to you Juan.

Thanks, Manish. Let me wrap up by highlighting some of the ways we are setting our business up for the back half of 2025 and into 2026 along with the positive signals we see that are providing momentum. Overall, we will continue to drive operational excellence through our focus on cost savings and cash and by simplifying our business through targeted portfolio optimization, including the recent examples I mentioned earlier in today's call. In Carbohydrin Solutions, we'll continue to drive operational excellence and closely monitor both consumer sentiment and broader economic signals, while maintaining momentum around our decarbonization and cost reduction initiatives. For Nutrition, the ramp up of the Cater East and optimized portfolio will support continued recovery of the business, while we focus on building upon our strong opportunity pipeline in segments like Flavors and Health and Wellness.

In Ag Services and Oilseeds, our active network optimization and operations focus is positioning us with the agility to capture opportunities from improved market conditions in the back half of the year. Additionally, we're closely monitoring global trade developments, particularly in relation to China and broader export market dynamics as we head into the critical U. S. Harvest season later this year. These factors will play an important role in shaping opportunities in the months ahead.

We are seeing selective market share increases that are offsetting sluggish markets elsewhere and we are sharpening our focus on good risk management practices. Looking to the 2025 and onwards, we see several reasons for optimism. Clarity in biofuel policy and legislative support for agriculture are creating a favorable environment for market access for our farmer partners and enhance ADM's ability to deliver economic value to the broader sector. The foundational work we've done in the 2025 set us for stronger operational momentum. Our investments in innovative spaces such as postbiotics, natural flavors and colors and decarbonization position us to capture growth in high potential markets.

We have recalibrated many variables as we navigate the current complexities, and our confidence in ADM's resilience stems from the dedication and expertise of our team. Their ability to adapt to challenges and execute against our strategy has been evident throughout the year. We are a company built to endure cycles and our unparalleled asset network combined with the ingenuity of our workforce ensures we remain a source of strength for our farmers, customers and partners. As we move forward, our focus on self help initiatives, execution excellence and disciplined capital allocation will continue to drive value for our shareholders and position ADM for success in 2026 and beyond. With that, let's open the line for questions. Operator?

Thank you. Our first question for today comes from Andrew Strelzik of BMO. Your line is now open. Please go ahead.

Hey, good morning. Thanks for taking the question. You gave a lot of helpful color for the back half of the year, but I was hoping you could maybe a little bit more explicitly give us kind of the earnings split between 3Q and 4Q or at least a little bit more guide kind of at the total company level. If I take that, does it make sense to as we start to think about 2026 annualized 4Q as kind of a starting point? I know it's a bit of a bigger quarter, so we can make some mental math adjustments around that. But is there any reason why that kind of doesn't make sense to you? Thanks.

Well, thank you for the question. As you said or you imply in your question, we see the perspectives for ADM improving and getting more clearer as we go into the second half. Of course, first half has a lot of headwinds. Second half with the benefits now of a little bit more clarity on RBOs and 45Z, we certainly see the potential for soybean oil to be much more demanded and that will be the preferred feedstocks for North America. Unfortunately, by the time this was announced, we have already contracted more most of our Q3.

So you will see the impact for us mostly in Q4. So as such, it's probably going to be something in the, I don't know, five, sixty five type of split between Q3 and Q4. If you think about what are the things that we have in Q4 coming for us. We continue with our improvement in cost position. We're going to see an improvement in crush margins if all these RVO numbers are finally confirmed.

We're going to see the benefit of our East plant in Nutrition being back into production. And we're going to see better earnings from our services as we get into our export season and probably from a global trade perspective as well. So we have high expectations from that quarter provided all these RBOs are confirmed. In terms of 2026, probably too early, but most of the time we said the rate that we exit 2025 becomes the rate that when we enter 2026. Whether that's going to be multiplied by four, too early to speculate at this point.

Just Andrew, a couple more data points, Two points point, one third, two third split q three, q four. Secondly, just as you're modeling, just remember last year we had 230,000,000 of insurance proceeds. 96 of it was in q three and the balance was in q four. And you can see the segments. So in q three, carbs will be the biggest impact on a year over year basis.

If crush margins don't move up or the replacement curve doesn't move up, that's another $0.15 headwind, if the curve doesn't move. Corporate, usually second half is usually higher than the first half due to some naturally seasonal items. We'll continue to drive our cost and cash initiatives that we have. Ethanol, when you think about ethanol, it's still lower on a year over year basis. While the second quarter was positive, it was still lower than than than the total than last year.

And so we continue to see ethanol to be a little softer in the second half. But all of that is currently baked into our guide except, of course, the headwind if the if the replacement curve doesn't work. And timing is another item that could move between quarters or where our our mark comes at the end of the year. But, hopefully, that answers your question.

Yes. That's very helpful. Thank you very much.

you. Our next question comes from Ben Thoreau of Barclays. Your line is now open. Please go ahead.

Yes, good morning. Thank you very much, Juan, Monish. Congrats on the solid results for the second quarter. I wanted to dive into the outlook for the Nutrition segment into the back half, obviously, with Decatur East coming back, as we look into this and kind of like have like an LTM run rate, kind of, call it, about EUR 400,000,000 operating income now in that segment. But clearly, with all these headwinds, what would you suggest us assuming has been kind of like that incremental cost that you called out for not having Decatur East over the last couple of quarters?

And as we ramp this through 3Q into 4Q and then particularly into 2026, where do you think like kind of like a current run rate is for that business on a stand alone basis? Thank you.

Yeah. Thank you for the question, Ben. Let me address nutrition and how is it going. So nutrition continues recovery. We're very pleased with that.

If I take it into pieces, if you take animal Human Nutrition, Human Nutrition is being driven by flavors, strong revenue growth. We are holding to our EBITDA margin. So we are very pleased with that, mostly driven by beverages in North America, but also strength in Europe. And we have an opportunity to grow geographically as our plants in Asia Pacific are increasing output. In terms of health and wellness, Biotics has grown so far 9% revenue.

So that's going very, very well. And we are very pleased with that. And we will be releasing some data of studies that we perform in 2025. We're going to be or in the past we will be releasing in 2025 and 2026 that will give much more opportunities for us to penetrate more applications, especially in the heat treated postbiotic area where ADM is one of the leading companies. In terms of Specialty Ingredients was the headwinds for the Human Nutrition part.

And as you said, we have mentioned before the headwinds in terms of cost for having the Decatur plant down was about 20,000,000 to $25,000,000 per quarter. That will be hopefully be behind us as we go into 2026. So then you have the Animal Nutrition. The Animal Nutrition side has been an improvement story, you will, a margin up story. Remember, I mentioned that from the time that from like three or four years ago.

And they've been executing on that. They've been executing for the last I think seven quarters. They've been presenting better results based on self help. The market is a relatively good market in the sense that all the protein customers are making money. Feed is relatively cheap right now, so profitability is there.

And our portfolio is slightly shifting into more specialty products as we go along. So we are deemphasizing some of the commodities and emphasizing a little bit more our innovation in those segments. So we feel good about that. Please continue. So I think we are setting up well for continued growth into 2026.

Numbers wise, the run rate, I wouldn't like to venture at this point in time. But I think you can, for sure, add about $100,000,000 of specialty ingredient headwinds that we're not going to have in 2026. The plant so far is running well since it started up back. The team brought it back safely. So we're very proud of the team. So, so far so good.

Thank you. Our next question comes from Manav Gupta of UBS. Your line is now open. Please go ahead.

Monish, I just want a little bit of a clarification. I know you had been working very closely with SEC responding to all these queries. And now you're putting out a statement that the material weakness is no longer there. So am I are we to understand that you reached out to SEC, you gave them what they wanted, and then they did not come back with additional questions. So at this point, would it be fair to say that SEC is okay with your way your financials are being constructed?

And what can also be done to make sure this never happens again, if you could just talk about those things? Thank you.

Yes. Manav, I think there are two two different, points that maybe I can make. Number one is, yes, we did remediate the material weakness this quarter, and the team did a really heavy job. They had created if you think it's eighteen months that the company has worked on this robust remediation plan. So we designed and implemented a lot of enhanced internal, controls, especially in related to our intersegment policies, pricing, and measurement controls, which was the the reason for the material weakness.

We improved our training. We upgraded talent. We have tested these controls and right and we've test them over multiple periods. And right now, we believe these are effective. The way we do this, Manav, just for your benefit, is management tested.

They have their controls. They test it. And then at the end of the day, we consult with the audit committee as well as our auditors to make sure that what we are doing, has has robust internal control. So we have actively engaged our auditors while their while the audit will not be complete till the 10 k is filed, the auditors do have a obligation to make sure that what we are publicly disclosing is accurate as well as they feel good that our internal controls have been met. So based on all of that, that we have made sure that our controls are working, We as management feel that the material weakness has been remediated.

And as I said, it's in consultation with our auditors and the audit committee. I would say going forward, we will continue this journey. So we will continue to keep focusing on broader initiatives that will enhance our transparency and compliance processes while continuing to maintain an effective operating end. So hopefully, answered your question, Manav. This is based on a robust remediation plan, and we have tested it.

And we feel that over the last few quarters that these controls have been effective. And that's why we felt that we are in a position to remediate the material weakness this quarter.

Thank you. Our next question comes from Heather Jones of Heather Jones Research. Your line is now open. Please go ahead.

Good morning. Thanks for the question. I had a two part question on crush, and first part was just a clarification. Wondering when you say if the replacement curve doesn't move up from here, are you referring to physical? And then secondly, more big picture, question.

If the RVO SREs play out as benignly as expected, just wondering the benefits to your biodiesel business, but more importantly to your global crush business. When we think about how that business was doing in 2223, how would you think about how ADM would be decision going into '26 and '27 if that plays out, you know, if the if the policy picture plays out as we're expecting? Thank you.

So just a quick one, Heather, to answer your question. When we think about the replacement curve, yes, we do look at bold crush, but at the end of the day, margins have to show up on the cash side, and that's that's the curve that I've mentioned. Mentioned. So we're combining both and that's where I came up with the math that I gave you. Now that will move every day depending on how markets move, but this is where we are at this point in time.

Yeah. Heather, on on the big picture perspective, as you said, the RVOs have been very positive for soybean oil and that can certainly increase demand. There are going to be adjustments. If you think about at this point in time or in the first half we were exporting soybean oil and we probably won't do that. And some of our customers are already some of our food customers are we are already offering different mixes of products.

Of course, we have peanut oil and cotton oil and rapeseed oil and we have many different blends because soybean oil will be a preferred feedstock for biofuels. So I think that we will adjust and we will maximize the profitability for the envelope. If you think about where the margins will fall, so I think initially we will probably have to see RINs popping up. We will see probably the benefits landing in the crush because we're going to have these very strong legs in terms of oil, but also in biodiesel. I think refining will probably be a little bit of squeezed refining margins because of all the pretreatment capacity and we'll have to see how many people run these pretreatment capacities, how many of the refineries come on the stream.

But that's the way we see it. We feel very comfortable that the places where we have crush where you have Brazil and you're going to have a B14 to B15 and then the progression of increasing that. The U. S. Will have the RBOs.

And then in Europe, Germany has abolished the double counting, which also is going to be good for rapeseed oil. So all in all, can see about 6,000,000 tonnes of extra feedstocks coming into the biofuel area that you add about 800,000 tons of growth in the food, it gives a very good perspective for this. You will see oil taking about 50% of the share of the crush, which hasn't happened in quite a while. And every time that happens, of course, margins pop up. So we will have to put pencil to all that when the RBOs are done.

But I think if all this is confirmed and the SREs are kept in check, I think it plays very well for ABM going forward.

Thank you. Our next question comes from Pohrman Sharma of Stephens. Your line is now open. Please go ahead.

Good morning and thanks for the question. I was wondering if maybe we could get a little bit more detail on the network optimization plan. I know you you mentioned some detail in your prepared remarks, including some facilities that you had shut down in in different geographies, but you also mentioned that there's there's some room to go. And so was, a, just wondering, you know, where, you know, where do you see the most room for kind of your your further optimization? Is it more ag services, processing?

Would just love a little bit of color there. And then also, how does this optimize your processing kind of OpEx? Like, should we be looking at like a $5 per metric ton improvement? Or how should we think about it from a crush perspective?

Yes. Thank you. Yes, I think that performance improvement around operations is one of the things that we highlighted early in the year we're going to focus on and we are delivering on that. I'm very proud of the improvements of the team. We were preparing our footprint for all these potential RVO improvements and the ability to have to crash at full rates going forward.

So thankfully, we have the beans to do that and we needed to have the plants in good shape. So we spent a lot of time optimizing the network. I'm pleased to report as we said in our prepared remarks that some of our unscheduled downtime is in on rates that we haven't seen since February. So it's been 2020, I'm sorry, not February. It's been very good in that regard.

I will say selectively we tend to look at we have many plans and we tend to look instead of having individual plans and pockets of that, we tend to look at the network and what optimizations can we do to keep plans or expanding plants that are that have lower cost position and maybe retiring plants that have a challenged cost position. We do that across the portfolio. We've done it in milling. We do it in Oilseeds and Ag Services. In Ag Services, we constantly shifting the elevators that we own.

At times, we sell them. At times, we trade them with or we swap them for others. At times we shut them down or we sell them. The same happened with the facilities. We announced the Kershaw shutdown.

We announced in the joint venture of Lubuk, which is for cottonseed oil. So you're going to see that no spectacular announcement, but a continued trickle down of optimization. We have a large footprint and we have targets to optimize our cost base. I'm not going to disclose them right now. I want to see more stability of the run rates and we still have a few things that we need to get done before maybe we give those numbers.

But needless to say, we're very happy with how our plants are operating in the face of again hopefully a few years of very high crush rates.

Thank you. Our next question comes from Hayne of Morgan Stanley. Your line is now open. Please go ahead.

Good morning. Thanks for taking my question. Wanted to come back to something on the RVO. It seems like since the proposal, RD margins have kind of remained pressured and almost all the value has kind of accrued back to the crush complex. So would be curious to hear some thoughts on why you think that is and whether or not you would expect that to kind of remain that way? Thank you.

Yes. Well, this is a very difficult period you need to understand. We were giving an indication of what may happen. But then there are a lot of rumors one day or the other that are shifting this because the whole numbers have not been confirmed. So although we feel optimistic about the future, we are in an uncertain period until the final numbers are clarified.

What are the final RBOs? How are we going to treat SREs? So I would say, we shouldn't take a lot of cues from right now what's happening. I think that we know what happened with industry crush margins when oil in the past have taken about 50%, 52% of the crush. So I wouldn't read that much right now until we get more clarity.

It's still this is still a forecast. And I think you need to see we have produced very little to comply with the mandates in the first half of an industry. So we will have to pick up those rates in the second half when all this clarity is given. So we see accelerated production. And you're going to see RINs reacting first.

At this point in time, there's still I mean, they are much bigger than much higher than they were last year. They moved like from $0.40 to $1.15 or $1.16 or whatever they are. So but we still have rooms to go there. So I think that we are watching it closely. As I said, in the meantime, we're getting ready.

There is a big crop coming. Our plants are ready to crush. So when we have the indication, we are well positioned to do so.

you. Our next question comes from Salvator Tiano of Bank of America. Your line is now open. Please go ahead.

Yes, thank you. Firstly, you can I may have misunderstood or missed it before, you can clarify a little bit the $100,000,000 benefit from the Decatur restart is at 26,000,000 versus $25,000,000 or the eventual benefits, which includes 25 tailwinds? But my primary question is on high fructose corn syrup, we also the news a few weeks ago about Coca Cola potentially shifting away into cane sugar. And I'm just wondering if you can help us a little bit better understand how big this business is for you in terms of perhaps anything like volume, revenues, EBIT as well as what is the risk if other companies follow suit to the industry?

Yes, Salvator. So what's the first question? The €100,000,000 Oh, yes.

Yes, yes. Sorry for that. Yes. Decatur cost us basically when it was shut down about 20,000,000 to $25,000,000 per quarter. So Decatur is back up now.

So you should consider that starting Q4 for the full quarter, that's going to be an impact of run rate from that moment onward. And then hopefully, if it continues to run and nothing happens, you will put that into it. But I would say for 2025, you should consider that we have like three quarters of that cost still with us because the plant is ramping up and we still probably have inventory of material that we have bought that needs to go and run through the cost of goods sold. On the high fructose corn syrup, listen, this is we have relationships here in this market that go back decades with the key players. And we have relationship at every level.

And at this point in time, we have no indication of any changes in their order pattern or their projections nor we have seen any volume changes based on any announcement. So I would say in that regard, we are not planning on any change. I would say that this business has been working on what we call the fight for the grind. We make more than 22 products in our wet mill. And if you think about it, high fructose corn syrup has been a slightly declining 1% or 1.5% since I've been here.

So and we've been managing to have a carb solution business that is very stable based on optimization, product mix, development of new products like when we highlight BioSolutions, product like glucose for fermentation. So there are a lot of opportunities for us to do. This is a big market and we plan to continue to supply it. But we've been servicing the beverage industry again for multiple decades and we've always been very flexible and adjusting to the conditions. Conditions.

And at times, it's with natural colors or flavors, at times it's with high fructose corn syrup, at times it's with other solutions to reduce sweetness. So we will continue to be a major player in that. But at this point in time, I want to tell you there's no change in our volumes in high fructose corn syrup.

Archer Daniels Midland (ADM) Q2 2025 Earnings Call Transcript

Company Participants